An expert discusses how rilzabrutinib, a recently FDA-approved Bruton tyrosine kinase (BTK) inhibitor, targets the autoimmune pathophysiology of immune thrombocytopenia (ITP) by modulating B cells, ...

If you’ve ever discovered a mysterious bruise on your body, you’ve probably tried to retrace your steps. Maybe you slammed into that doorknob harder than you thought, or maybe stumbling to the ...

A panelist discusses how ITP diagnosis remains one of exclusion requiring thorough testing to rule out other causes of thrombocytopenia, followed by patient education about autoimmune diseases and ...

This might sound surprising, but getting diagnosed with immune thrombocytopenia (also known as idiopathic thrombocytopenic purpura, or ITP) can come as a relief. You can figure out ITP treatment, of ...